Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for Prevention of Uterine Fibroids
NCT03586947Unknown
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Sep 2018
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of cholecalciferol in Uterine Fibroids (UF) (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Incidence rate of uterine fibroids in different groups at 2 years. Status: unknown.
02
Drugs
cholecalciferol
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03586947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586947.